AngioDynamics Inc expected to post a loss of 9 cents a share - Earnings Preview

AngioDynamics

10/07/2026 13:39

AngioDynamics Inc ANGO.OQ ANGO.O is expected to  show a rise in quarterly revenue when it reports  results on July 14 for the period ending May 31 2026
The Latham New York-based  company is expected to report a 0.3% increase in revenue to $80.4 million from $80.16 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
​LSEG's mean analyst estimate for AngioDynamics Inc is for a loss of 9 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for AngioDynamics Inc is $16.00, about 23.8% above its last closing price of $12.92
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Feb. 28 2026
-0.11
-0.11
0.02
Beat
118.2
Nov. 30 2026
-0.10
-0.10
0.00
Beat
100
Aug. 31 2025
-0.12
-0.12
-0.10
Beat
14.9​
May. 31 2025
-0.13
-0.12
-0.03
Beat
75
​​Feb. 28 2025
-0.14
-0.13
0.03
Beat
123.1
Nov. 30 2024
-0.10
-0.11
-0.04
Beat
63.6​
Aug. 31 2024
-0.15
-0.15
-0.11
Beat
25
May. 31 2024
-0.16
-0.17
-0.06
Beat
64
This summary was machine generated July 10 at 12:39 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)